CSF P-tau 231 as Biomarker in Alzheimer's Disease.
作者信息
Mukherjee Adreesh, Biswas Atanu
机构信息
Department of Neurology, Institute of Post Graduate Medical Education and Research (IPGME&R) and Bangur Institute of Neurosciences, Kolkata, West Bengal, India.
出版信息
Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):995-996. doi: 10.4103/aian.aian_858_22. Epub 2022 Nov 23.
Abstract
摘要
相似文献
1
CSF P-tau 231 as Biomarker in Alzheimer's Disease.脑脊液中磷酸化tau蛋白231作为阿尔茨海默病的生物标志物
Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):995-996. doi: 10.4103/aian.aian_858_22. Epub 2022 Nov 23.
2
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用：系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
3
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.脑脊液 tau 片段与 tau PET 相关： tangle 病理学的候选生物标志物。
Brain. 2020 Feb 1;143(2):650-660. doi: 10.1093/brain/awz346.
4
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.标志物 A+T-：这是阿尔茨海默病吗？一项联合脑脊液和病理学研究。
Brain. 2023 Mar 1;146(3):1166-1174. doi: 10.1093/brain/awac158.
5
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系：一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
6
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.唐氏综合征成人阿尔茨海默病的血浆和脑脊液生物标志物：一项横断面研究。
Lancet Neurol. 2018 Oct;17(10):860-869. doi: 10.1016/S1474-4422(18)30285-0. Epub 2018 Aug 29.
7
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.
8
N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.N 端和中部tau 片段作为神经疾病的液体生物标志物。
Brain. 2022 Aug 27;145(8):2834-2848. doi: 10.1093/brain/awab481.
9
Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer's Disease.阿尔茨海默病快速进展型和缓慢进展型的脑脊液线粒体 DNA。
Int J Mol Sci. 2020 Aug 31;21(17):6298. doi: 10.3390/ijms21176298.
10
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.阿尔茨海默病脑脊液生物标志物可预测路易体痴呆的认知衰退。
Mov Disord. 2016 Aug;31(8):1203-8. doi: 10.1002/mds.26668. Epub 2016 Jun 14.
本文引用的文献
1
P-tau231 as a Diagnostic Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.P- tau231作为阿尔茨海默病和轻度认知障碍的诊断生物标志物：一项系统评价和荟萃分析。
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):845-851. doi: 10.4103/aian.aian_77_22. Epub 2022 Oct 31.
2
Alzheimer's disease: pathogenesis, diagnostics, and therapeutics.阿尔茨海默病：发病机制、诊断和治疗。
Int J Nanomedicine. 2019 Jul 19;14:5541-5554. doi: 10.2147/IJN.S200490. eCollection 2019.
3
Clinical and biomarker changes in dominantly inherited Alzheimer's disease.常染色体显性遗传阿尔茨海默病的临床和生物标志物变化。
N Engl J Med. 2012 Aug 30;367(9):795-804. doi: 10.1056/NEJMoa1202753. Epub 2012 Jul 11.
4
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.阿尔茨海默病及相关疾病中tau蛋白介导的神经退行性变。
Nat Rev Neurosci. 2007 Sep;8(9):663-72. doi: 10.1038/nrn2194.
5
Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.脑脊液生物标志物可预测健康老年人3年内主观认知功能的下降。
Dement Geriatr Cogn Disord. 2007;24(2):118-24. doi: 10.1159/000105017. Epub 2007 Jul 2.
6
Tauopathies.tau蛋白病
Cell Mol Life Sci. 2007 Sep;64(17):2219-33. doi: 10.1007/s00018-007-7220-x.
7
Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women.脑脊液β-淀粉样蛋白1-42浓度可能预测老年女性的认知衰退。
J Neurol Neurosurg Psychiatry. 2007 May;78(5):461-4. doi: 10.1136/jnnp.2006.100529. Epub 2006 Nov 10.
8
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.脑脊液磷酸化tau蛋白与阿尔茨海默病的新皮质神经原纤维病理改变相关。
Brain. 2006 Nov;129(Pt 11):3035-41. doi: 10.1093/brain/awl269. Epub 2006 Sep 29.
9
Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia.总tau蛋白和磷酸化tau蛋白：作为额颞叶痴呆核心生物标志物候选物的评估
Dement Geriatr Cogn Disord. 2004;17(4):350-4. doi: 10.1159/000077170.
10
Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.与对照组相比，脑脊液tau蛋白在年轻老年人（<70岁）的阿尔茨海默病患者中比在高龄患者中表现出更好的辨别能力。
Neurosci Lett. 1999 Dec 17;277(1):21-4. doi: 10.1016/s0304-3940(99)00845-9.
Zotero 插件